Stress Urinary Incontinence Device Market Size, Share & Trends Analysis Report By Product (Sling Systems, Vaginal Pessary Devices, Artificial Urinary Sphincter (AUS), Pelvic Floor Muscle Stimulator, and Injectable Urethral Bulking Agents/Injections), By End-Users, Region And Segment Forecasts, 2025-2034

Report Id: 1142 Pages: 180 Last Updated: 23 June 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Stress Urinary Incontinence Device Market Segmentation

Global Stress Urinary Incontinence Device Market Based on Product

  • Sling Systems
  • Vaginal Pessary Devices
  • Artificial Urinary Sphincter (AUS)
  • Pelvic Floor Muscle Stimulator
  • Injectable Urethral Bulking Agents/Injections

Stress Urinary Incontinence Device Market

Global Stress Urinary Incontinence Device Market Based on End user

  • Hospitals
  • Gynecological Clinics
  • Homecare Settings

Global Stress Urinary Incontinence Device Market Based on Region

Europe

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Stress Urinary Incontinence Device Market Snapshot

Chapter 4. Global Stress Urinary Incontinence Device Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Market Dynamics - Drivers

4.3. Challenges/Restraints

4.4. Market Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. SUI Epidemiology Analysis in Key Countries 2019

4.7. COVID 19 Impact on Medical Device Industry 2020

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2024 & 2034

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:

5.2.1. Sling Systems

5.2.2. Vaginal Pessary Devices

5.2.3. Artificial Urinary Sphincter (AUS)

5.2.4. Pelvic Floor Muscle Stimulator

5.2.5. Injectable Urethral Bulking Agents/Injections

Chapter 6. Stress Urinary Incontinence Device Market Segmentation 2: End-user Estimates & Trend Analysis

6.1. End-user Analysis & Market Share, 2024 & 2034

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-user:

6.2.1. Hospitals

6.2.2. Gynecological Clinics

6.2.3. Homecare Settings

Chapter 7.  Stress Urinary Incontinence Device Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034

7.1.2. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034

7.1.3. North America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2021-2034

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034

7.2.2. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034

7.2.3. Europe Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034

7.3.2. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034

7.3.3. Asia Pacific Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, 2021-2034

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034

7.4.2. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034

7.4.3. Latin America Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2021-2034

7.5.2. MEA Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2021-2034

7.5.3. MEA revenue Stress Urinary Incontinence Device Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2021-2034

7.5.3.1. South Africa

7.5.3.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Coloplast A/S

8.2.1.1. Company Overview

8.2.1.2. Financials

8.2.1.3. Product portfolio

8.2.1.4. Business strategy & Recent developments

8.2.2. Contura Ltd.

8.2.3. Elidah, Inc.

8.2.4. Laborie, Inc. (Cogentix Medical)

8.2.5. Atlantic Therapeutic

8.2.6. Boston Scientific Corporation,

8.2.7. Johnson & Johnson Services. Inc.

8.2.8. BD

8.2.9. CooperSurgical, Inc.

8.2.10. MEDGYN PRODUCTS, INC.

8.2.11. Cousin Biotech

8.2.12. Caldera Medical

8.2.13. Betatech Medical

8.2.14. FEG Textiltechnik mbH.

8.2.15. Affluent Medical

8.2.16. pfm medical ag

8.2.17. Betatech Medical

8.2.18. Caldera Medical Inc

8.2.19. Neomedic International

8.2.20. UROMED

8.2.21. Zephyr Surgical Implants

8.2.22. Viveve Medical, Inc.

8.2.23. UroMems

8.3. List of Other Prominent Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
3700
Security Code field cannot be blank!

Frequently Asked Questions

The Stress Urinary Incontinence Device Market is expected to grow at an 5.5 % CAGR during the forecast period for 2025-2034.

Coloplast A/S, Contura Ltd., Laborie, Inc. (Cogentix Medical), Atlantic Therapeutics, Boston Scientific Corporation, Johnson & Johnson Services. Inc.,

Product and End-Users are the key segments of the Stress Urinary Incontinence Device Market.

North American region is leading the Stress Urinary Incontinence Device Market.
Get Sample Report Enquiry Before Buying